Senores Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | ||
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 30.51 | 9.82 | 8.74 | 3.80 | |
Reserves | 137.61 | 29.11 | 24.95 | 5.67 | |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Shareholders Funds | 168.12 | 38.93 | 33.69 | 9.47 | |
Secured Loans | 14.58 | 3.01 | 1.99 | 0.49 | |
Unsecured Loans | 79.54 | 57.65 | 12.76 | 3.22 | |
Total Debt | 94.12 | 60.66 | 14.75 | 3.71 | |
Other Liabilities | 7.22 | 1.84 | 0.05 | 0.00 | |
Total Liabilities | 269.46 | 101.43 | 48.49 | 13.18 | |
APPLICATION OF FUNDS : | |||||
Gross Block | 26.08 | 8.29 | 2.87 | 2.26 | |
Less: Accumulated Depreciation | 2.00 | 0.52 | 1.28 | 0.57 | |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Block | 24.08 | 7.77 | 1.59 | 1.69 | |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Work in Progress | 18.47 | 11.33 | 3.17 | 2.71 | |
Investments | 81.58 | 8.23 | 11.69 | 1.45 | |
Current Assets, Loans & Advances | |||||
Inventories | 4.52 | 3.12 | 2.98 | 0.34 | |
Sundry Debtors | 22.01 | 15.73 | 8.37 | 0.23 | |
Cash and Bank Balance | 10.44 | 0.09 | 1.41 | 1.64 | |
Loans and Advances | 2.98 | 8.74 | 1.22 | 5.98 | |
Total Current Assets | 39.95 | 27.68 | 13.98 | 8.19 | |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 15.20 | 9.75 | 6.53 | 1.58 | |
Provisions | 1.20 | 0.55 | 0.14 | 0.20 | |
Total CL & Provisions | 16.41 | 10.30 | 6.67 | 1.79 | |
Net Current Assets | 23.55 | 17.38 | 7.31 | 6.41 | |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets | 0.21 | 0.18 | 0.45 | 0.77 | |
Deferred Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Deferred Tax | 0.21 | 0.18 | 0.45 | 0.77 | |
Other Assets | 121.56 | 56.53 | 24.28 | 0.14 | |
Total Assets | 269.46 | 101.42 | 48.49 | 13.18 | |
Contingent Liabilities | 0.00 | 0.00 | 0.13 | 0.13 |